# OnCo record neonc-technologies (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/neonc-technologies/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "neonc-technologies" ;
  schema:name "Neonc Technologies"@en ;
  schema:alternateName "Neonc Technologies, Inc."@en ;
  schema:description "Neonc Technologies is a United States-based biotechnology company running 3 late-stage cancer trials of NEO212 Oral and NEO100 in glioma & glioblastoma, cervical cancer and colorectal cancer."@en ;
  schema:url <https://onco.cc/companies/neonc-technologies/>, <https://www.neonc.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.neonc.com>, <https://clinicaltrials.gov/search?lead=Neonc%20Technologies%2C%20Inc.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "US" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/merkel-cell-carcinoma/> ;
  onco:trials <https://onco.cc/trials/nct06047379/>, <https://onco.cc/trials/nct02704858/> .